晶片生產商恩智浦(NXPI.US)季度盈利勝預期
荷蘭晶片生產商恩智浦(NXPI.US)公佈截至10月1日止第三財季業績。季度經營溢利按年跌1%至9.92億美元,每股季度攤薄純利3.01美元,經調整後爲3.7美元,高於市場預期的3.59美元。
季度收入按年跌不足1%至34.34億美元,市場預期爲34億美元。其中移動部門收入按年跌8%至3.77億美元,公司生產的近距離無線通訊晶片用於手機內,以支持手機支付及其他功能,外界相信蘋果(AAPL.US)爲其主要客戶。汽車部門收入按年升5%至18.91億美元。
公司預測現季度經調整收入介乎33億至35億美元,市場預期爲34.3億美元。每股經調整盈利料介乎3.44至3.86美元,市場預期爲3.61美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.